A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
Status:
Withdrawn
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and
maraviroc gel and determine whether it is safe for daily use by healthy women in the United
Kingdom